Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

por Moreno, Alberto, Manning, Kelly, Azeem, Maryam I., Nooka, Ajay K., Ellis, Madison, Manalo, Renee Julia, Switchenko, Jeffrey M., Wali, Bushra, Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Dhodapkar, Kavita M., Dhodapkar, Madhav V., Suthar, Mehul S.
Publicado 2023

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

por Nooka, Ajay K., Shanmugasundaram, Uma, Cheedarla, Narayana, Verkerke, Hans, Edara, Venkata V., Valanparambil, Rajesh, Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Azeem, Maryam, Manalo, Julia, Switchenko, Jeffrey M., Chang, Andres, Linderman, Susanne L., Roback, John D., Dhodapkar, Kavita M., Ahmed, Rafi, Suthar, Mehul S., Neish, Andrew S., Dhodapkar, Madhav V.
Publicado 2022

Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy

por Robinson, M. Hope, Villa, Nancy Y., Jaye, David L., Nooka, Ajay K., Duffy, Alyssa, McCachren, Samuel S., Manalo, Julia, Switchenko, Jeffrey M., Barnes, Sierra, Potdar, Sayalee, Azeem, Maryam I., Horvat, Ava A., Parihar, Vaunita C., Gong, Jingjing, Liang, Yan, Smith, Geoffrey H., Gupta, Vikas A., Boise, Lawrence H., Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Dhodapkar, Kavita M., Dhodapkar, Madhav V.
Publicado 2023